Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson's and Alzheimer's disease.

Gellhaar S, Sunnemark D, Eriksson H, Olson L, Galter D.

Cell Tissue Res. 2017 Sep;369(3):445-454. doi: 10.1007/s00441-017-2626-8. Epub 2017 May 2.

2.

Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden.

Ran C, Brodin L, Forsgren L, Westerlund M, Ramezani M, Gellhaar S, Xiang F, Fardell C, Nissbrandt H, Söderkvist P, Puschmann A, Ygland E, Olson L, Willows T, Johansson A, Sydow O, Wirdefeldt K, Galter D, Svenningsson P, Belin AC.

Neurobiol Aging. 2016 Sep;45:212.e5-212.e11. doi: 10.1016/j.neurobiolaging.2016.04.022. Epub 2016 May 3.

3.

Chronic L-DOPA induces hyperactivity, normalization of gait and dyskinetic behavior in MitoPark mice.

Gellhaar S, Marcellino D, Abrams MB, Galter D.

Genes Brain Behav. 2015 Mar;14(3):260-70. doi: 10.1111/gbb.12210. Erratum in: Genes Brain Behav. 2015 Jun;14(5):442.

4.

Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration.

Tsika E, Kannan M, Foo CS, Dikeman D, Glauser L, Gellhaar S, Galter D, Knott GW, Dawson TM, Dawson VL, Moore DJ.

Neurobiol Dis. 2014 Nov;71:345-58. doi: 10.1016/j.nbd.2014.08.027. Epub 2014 Aug 29.

5.

LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4.

Häbig K, Gellhaar S, Heim B, Djuric V, Giesert F, Wurst W, Walter C, Hentrich T, Riess O, Bonin M.

Biochim Biophys Acta. 2013 Dec;1832(12):2352-67. doi: 10.1016/j.bbadis.2013.09.009. Epub 2013 Sep 24.

6.

Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models.

Hedskog L, Pinho CM, Filadi R, Rönnbäck A, Hertwig L, Wiehager B, Larssen P, Gellhaar S, Sandebring A, Westerlund M, Graff C, Winblad B, Galter D, Behbahani H, Pizzo P, Glaser E, Ankarcrona M.

Proc Natl Acad Sci U S A. 2013 May 7;110(19):7916-21. doi: 10.1073/pnas.1300677110. Epub 2013 Apr 25.

7.

Neurodegenerative phenotypes in an A53T α-synuclein transgenic mouse model are independent of LRRK2.

Daher JP, Pletnikova O, Biskup S, Musso A, Gellhaar S, Galter D, Troncoso JC, Lee MK, Dawson TM, Dawson VL, Moore DJ.

Hum Mol Genet. 2012 Jun 1;21(11):2420-31. doi: 10.1093/hmg/dds057. Epub 2012 Feb 21.

8.

Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease.

Anvret A, Ran C, Westerlund M, Gellhaar S, Lindqvist E, Pernold K, Lundströmer K, Duester G, Felder MR, Galter D, Belin AC.

Behav Brain Res. 2012 Feb 1;227(1):252-7. doi: 10.1016/j.bbr.2011.10.040. Epub 2011 Nov 6.

PMID:
22079585
9.

Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease.

Good CH, Hoffman AF, Hoffer BJ, Chefer VI, Shippenberg TS, Bäckman CM, Larsson NG, Olson L, Gellhaar S, Galter D, Lupica CR.

FASEB J. 2011 Apr;25(4):1333-44. doi: 10.1096/fj.10-173625. Epub 2011 Jan 13.

10.

Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's disease.

Westerlund M, Behbahani H, Gellhaar S, Forsell C, Belin AC, Anvret A, Zettergren A, Nissbrandt H, Lind C, Sydow O, Graff C, Olson L, Ankarcrona M, Galter D.

FASEB J. 2011 Apr;25(4):1345-52. doi: 10.1096/fj.10-163402. Epub 2010 Dec 16.

Supplemental Content

Loading ...
Support Center